Fed. Circ. Affirms Invalidity Of Tyco Restoril Patent
The Federal Circuit on Wednesday upheld the invalidity of Tyco Healthcare Group LP's patent covering temazepam formulations for its sleep aid Restoril, which it asserted in an infringement suit against Mutual...To view the full article, register now.
Already a subscriber? Click here to view full article